"VR is a computer-generated scenario that simulates a realistic experience. The immersive environment can be similar to the real world to create real experiences based on reality or science fiction.
Augmented reality systems can also be regarded as VR shapes that encapsulate virtual information via camera feeds directly to the headset or through a smartphone or tablet device. ''
All you need for transformation is to enter the required software and configure the system. No need to replace the device itself. Only one set of equipment covers most of the clinic needs with VR technology. Field Vision Analyzer
The VR MED headset provides vision field analysis to enable doctors to diagnose early stage glaucoma. The initial test of the headset, completed at FH Aachen University of Applied Sciences, has confirmed the uniqueness and innovation of this product. Now the equipment is undergoing testing at the Institute of Eye Diseases at the Russian Academy of Sciences. Portability The VR MED headset is a mobile phone. To use it, the clinician only needs the headset itself, and a notebook to install. Its weight (0.4 kg, about one pound) and its compact dimensions add to the ease of transportation. These can be used in mobile medical units, small stationary clinics and with telemedicine settings. Ergonomic design
VR MED is integrated into the headset with ergonomic design, which is different from its competitors, providing a higher level of accuracy in fast eye tracking. It provides a versatile headset for use in a variety of medical settings. Multifunctional Medical Headset
Sales Token
About Token VRMD
Token: ERC 20 Protocol
Quantity: 24 000 000 Token
Price: 0.25 USD = 1 Token VRMD
Buy with: BTC ETH USD
All unsold tokens will be burned
Investment Attraction
VRMD Token is an in-house currency platform that allows the holder to:
Get products and access to services at cheaper rates than fiat currencies
Get access to update software, expand the functional capabilities of headsets, buy and sell data.
The open MED VR protocol platform implies additional information related to project information. The VR MED team claims that they will do their best to maintain the system, but will not be liable for any damages caused by such malicious actions. In addition, project codecs will be provided on the Etherium platform, and interruptions in their operations may have significant negatives to the performance of VRMD tokens.
VRMED Token
> Token Protocol ERC 20
> Total 30,000 000 Marketing token
> Price 0.25 USD = 1 Token VRMD
> Buy with BTC ETH USD
VRMD Token
> 20,000,000 VRMD - Mass sales
> 4,000,000 VRMD - Team, gift, or
> 6,000,000 VRMD - Reservation
VRMD Token is an in-house currency platform that allows the holder to:
Products and services for more than fiat currency
Access to software, expand functional headsets, buy, and sell data.
Take a role in fundraising for new medical development for VR MED Headset Share Demand will generate on inquiries and devices.
Roadmap
Prior to ICO
Starting from the development of VR headsets and programming that are suitable for medical use.
06.2016
Patents are given in Russia.
Starting from the process of receiving international patents
12.16-02.17
Model models of equipment and devices for screening glaucoma and other conditions with peripheral vision defects.
Successful trial results at the Institute of Eye Diseases at the Russian Academy of Sciences
02.17-04.17
Participation in international performances in Lisbon and Bahrain. Introduction device
04.17
The method can be used for FH Aachen University of Applied Sciences
05.17-07.17
Development of an Alpha version of the device, with the ability to provide solutions in ophthalmology (edge vision measurement, glaucoma diagnosis)
07.17-10.17
After the ICO
Starting from the development of VR headsets and programming that are suitable for medical use.
06.2016
Patents are given in Russia.
Starting from the process of receiving international patents
12.16-02.17
Model models of equipment and devices for screening glaucoma and other conditions with peripheral vision defects.
Successful trial results at the Institute of Eye Diseases at the Russian Academy of Sciences
02.17-04.17
Participation in international performances in Lisbon and Bahrain. Introduction device
04.17
The method can be used for FH Aachen University of Applied Sciences
05.17-07.17
Development of an Alpha version of the device, with the ability to provide solutions in ophthalmology (edge vision measurement, glaucoma diagnosis)
07.17-10.17
Final device development
(Technical use and fine-tuning), build improvements
03.18-06.18
ISO Standard 12866-2011. Development of industrial design
06.18-08.18
"Perimeter" software certification: Creation of a universal design for the diagnosis of various visual functions (through initial diagnosis of glaucoma and other peripheral vision defects)
08.18-12.18
Entry into the world market: Ending the approval process in Indian and Chinese clinics; international ISO certification
04.18-09.18
Upload user data to platform. Distribution of devices in the EU, Russia and Asia;
The launch of a decentralized platform;
The perimeter function is 100% for "gold standard" in eye diagnosis
05.18-07.19
Device widening functions include use in neurology and rehabilitation
05.18-07.19
Team
More Information Visit:
Website: https://stasyq.io/
Email: http://t.me/StasyQICO
Bulletin: https://stasyq.io/whitepaper.pdf
Facebook: https://www.facebook.com/stasyq
Twitter: https://twitter.com/stasyqICO
My Bitcointalk (Arumi.Bilqis): https://bitcointalk.org/index.php?action=profile;u=965668
ETH: 0x78A118ED0556B119ccafe86089a292A048234E79
Tidak ada komentar:
Posting Komentar